{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:36:52Z","timestamp":1781087812161,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ekir.2024.12.019","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T18:45:16Z","timestamp":1734720316000},"page":"803-815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Similar Efficacy in Belatacept-Converted Kidney Transplant Recipients With Steroid-Avoiding Regimen"],"prefix":"10.1016","volume":"10","author":[{"given":"Nathalie","family":"Chavarot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Cabezas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Lazareth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Try","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Scemla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jouve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Thervet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dany","family":"Anglicheau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Couzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sberro-Soussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 suppl 1","key":"10.1016\/j.ekir.2024.12.019_bib1","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.ajt.2023.02.004","article-title":"OPTN\/SRTR 2021\u00a0annual data report: kidney","volume":"23","author":"Lentine","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.019_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.1994.tb00098.x","article-title":"Steroid withdrawal after renal transplantation","volume":"8","author":"Schulak","year":"1994","journal-title":"Clin Transpl"},{"key":"10.1016\/j.ekir.2024.12.019_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1053-2498(99)00021-2","article-title":"Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation","volume":"18","author":"Sartori","year":"1999","journal-title":"J\u00a0Heart Lung Transplant Off Publ Int Soc Heart Transplant"},{"key":"10.1016\/j.ekir.2024.12.019_bib4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00007890-199702150-00001","article-title":"Hyperlipidemia in solid organ transplantation","volume":"63","author":"Kobashigawa","year":"1997","journal-title":"Transplantation"},{"issue":"12 suppl","key":"10.1016\/j.ekir.2024.12.019_bib5","first-page":"S75","article-title":"Steroid side effects and their impact on transplantation outcome","volume":"72","author":"Citterio","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2024.12.019_bib6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ndt\/16.4.829","article-title":"Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance","volume":"16","author":"Hjelmesaeth","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2024.12.019_bib7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0272-6386(99)70414-2","article-title":"Incidence and long-term cost of steroid-related side effects after renal transplantation","volume":"33","author":"Veenstra","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2024.12.019_bib8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.12.019_bib9","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1600-6143.2011.03504.x","article-title":"Chronic calcineurin inhibitor nephrotoxicity-lest we forget","volume":"11","author":"Chapman","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.019_bib10","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2024.12.019_bib11","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1159\/000351648","article-title":"Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence","volume":"37","author":"Issa","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2024.12.019_bib12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A\u00a0phase III study of Belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.019_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-6143.2011.03785.x","article-title":"Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients","volume":"12","author":"Vincenti","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.019_bib14","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2024.12.019_bib15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-6143.2010.03016.x","article-title":"A\u00a0phase III study of Belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)","volume":"10","author":"Durrbach","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.019_bib16","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1111\/ajt.13830","article-title":"Long-term outcomes in Belatacept- versus cyclosporine-treated recipients of extended criteria donor kidneys: final results from BENEFIT-EXT, a Phase III randomized study","volume":"16","author":"Durrbach","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.019_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-6143.2010.03338.x","article-title":"Immunosuppression with Belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients","volume":"11","author":"Ferguson","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.019_bib18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/ajt.15688","article-title":"Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: A prospective, randomized multicenter trial","volume":"20","author":"Woodle","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.019_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1096881","article-title":"Early calcineurin-inhibitor to Belatacept conversion in steroid-free kidney transplant recipients","volume":"13","author":"Tawhari","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ekir.2024.12.019_bib20","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1111\/ajt.16152","article-title":"Avoidance of CNI and steroids using Belatacept\u2014results of the Clinical Trials in Organ Transplantation 16 trial","volume":"20","author":"Mannon","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.019_bib21","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2215\/CJN.13100820","article-title":"Belatacept for simultaneous calcineurin inhibitor and chronic corticosteroid immunosuppression avoidance: two-year results of a prospective, randomized multicenter trial","volume":"16","author":"Kaufman","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.12.019_bib22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/ndt\/gfz255","article-title":"Opportunistic infections after conversion to Belatacept in kidney transplantation","volume":"35","author":"Bertrand","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2024.12.019_bib23","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/ajt.16430","article-title":"Increased incidence and unusual presentations of CMV disease in kidney transplant recipients after conversion to Belatacept","volume":"21","author":"Chavarot","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.019_bib24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1053\/j.ajkd.2016.09.021","article-title":"Safety and efficacy outcomes 3 years after switching to Belatacept from a calcineurin inhibitor in kidney transplant recipients: results from a Phase 2 randomized trial","volume":"69","author":"Griny\u00f3","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2024.12.019_bib25","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1097\/TP.0000000000002192","article-title":"Conversion to Belatacept in maintenance kidney transplant patients: A retrospective multicenter European study","volume":"102","author":"Darres","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2024.12.019_bib26","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.transproceed.2017.05.013","article-title":"Late conversion to Belatacept after kidney transplantation: outcome and prognostic factors","volume":"49","author":"D\u00fcrr","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ekir.2024.12.019_bib27","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1111\/ajt.14452","article-title":"Ten-year outcomes in a randomized phase II study of kidney transplant recipients administered Belatacept 4-weekly or 8-weekly","volume":"17","author":"Vincenti","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.019_bib28","first-page":"3479","article-title":"Opportunistic infections and efficacy following conversion to Belatacept-based therapy after kidney transplantation: A French multicenter cohort","volume":"9","author":"Bertrand","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ekir.2024.12.019_bib29","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1681\/ASN.2017060679","article-title":"Control of humoral response in renal transplantation by Belatacept depends on a direct effect on B cells and impaired T follicular helper-B cell crosstalk","volume":"29","author":"Leibler","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246802492403420X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246802492403420X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T08:32:47Z","timestamp":1744878767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246802492403420X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S246802492403420X"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2024.12.019","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Similar Efficacy in Belatacept-Converted Kidney Transplant Recipients With Steroid-Avoiding Regimen","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2024.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}